Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Greek Supreme Court To Rule On Legality Of Referendum

Fri, 03rd Jul 2015 10:15

LONDON (Alliance News) - The following is a summary of top news stories Friday.
----------
COMPANIES
----------
The Royal Bank of Scotland Group could face a penalty of as much as USD13 billion depending on the outcome of a US mortgage securities lawsuit, Bloomberg News reported. According to the report the US Federal Housing Finance Agency, which is suing on behalf of Fannie Mae and Freddie Mac, estimated that amount in a court filing in a related case.
----------
Anglo-Dutch consumer goods giant Unilever said it has agreed to buy US skincare company Murad. Terms of the deal were not disclosed. Founded in 1989 in Los Angeles, Murad, which had a turnover of USD115 million in 2014, will be incorporated into Unilever's Prestige division. The Murad deal follows Unilever's recent acquisitions of Dermalogica, Kate Somerville and REN.
----------
Ofcom has fined mobile operator EE GBP1 million for failing to comply with rules on handling customer complaints, the UK media and communications regulator said. EE is currently in the process of being acquired by telecoms company BT Group. The Ofcom investigation found EE did not provide certain customers with accurate or adequate information about their right to take their complaint to an alternative dispute resolution during the period under review, which covered July 22, 2011 to April 8, 2014.
----------
GlaxoSmithKline's ViiV Healthcare signed a strategic manufacturing agreement with Desano Pharmaceuticals on Thursday for the manufacturing of dolutegravir, ViiV's HIV medicine. The agreement will offer an additional source of the dolutegravir active pharmaceutical ingredient and will allow ViiV to offer a competitive supply of the finished product, marketed under the name Tivicay, for China and a number of developing countries, subject to national approvals.
----------
Ferrexpo said pellet production rose in the second quarter and in the first half as the company continues to produce more high-quality pellets. The iron ore miner operating in Ukraine said total pellet production in the second quarter experienced a small lift to 2.9 million tonnes, bringing total first half production to 5.8 million tonnes, which is up 8.3% from 5.4 million tonnes a year earlier.
----------
MARKETS
----------
London shares are mostly lower mid-morning, trading in a narrow range with the US stock market closed and ahead of the Greek referendum on its bailout provisions on Sunday.
----------
FTSE 100: down 0.3% at 6,610.30
FTSE 250: down 0.4% at 17,625.08
AIM ALL-SHARE: up 0.5% at 765.41
----------
The pound was higher against the dollar after UK Markit services Purchasing Manager's Index, the day's only domestic economic data, came in ahead of expectations.
----------
GBP: up at USD1.5632
EUR: up at USD1.1113

GOLD: up at USD1168.20 per ounce
OIL (Brent): down at USD61.69 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
Greek officials were braced for a decision by the country's supreme administrative court on the legality of the bailout referendum ahead of rival campaign rallies in central Athens. According to the Council of Europe, a democracy watchdog, Sunday's referendum will not meet international standards, as voters have not been given enough time to prepare and the question posed is too vague. But Triantafyllia Lina Papadopoulou, a professor of constitutional law at the Aristotle University of Thessaloniki, says the referendum is unlikely to be challenged. "Even if they go into the substance, I think it will be too late to annul the referendum," she told dpa.
----------
Greece requires at least EUR36 billion from Eurozone over the coming three years on concessional terms to maintain its finances sustainable, the International Monetary Fund said in a report. In a preliminary draft of its Greek debt sustainability analysis, the IMF said the funding requirement is projected to reach around EUR50 billion from October 2015 to end 2018, requiring at least EUR36 billion from European creditors on highly concessional terms.
----------
The UK service sector logged strong growth in June following a temporary lull in May linked to the recent election. The headline Markit/Chartered Institute of Procurement & Supply Purchasing Managers' Index rose to 58.5 in June from a five-month low of 56.5 in May. It was forecast to rise to 57.5. Data suggests that the second quarter of 2015 was the strongest on average since the third quarter of 2014.
----------
Ireland's service sector expanded at the fastest pace in almost nine years in June, driven by continued gains from improvements in economic conditions, survey figures from Markit Economics and Investec showed. The Investec services Purchasing Managers' Index rose to 63.3 in June from 61.4 in the previous month. A reading above 50 indicates expansion in the sector. The services activity increased at the strongest pace since September 2006.
----------
China's securities market regulator said that it has opened an investigation into suspected market manipulation. The China Securities Regulatory Commission said it has set up a team to look for "clues of illegal manipulation across markets" and irregularities between securities and futures trading."Those suspected of a crime will be resolutely transferred to the police for investigation," spokesman Zhang Xiaojun said in comments on the regulator's official microblog Thursday.
----------
The services sector in China continued to expand in June, but at a slower pace, the latest PMI from HSBC Bank showed, with a PMI score of 51.8. That's down from 53.5 in May, although it remains above the line of 50 that separates expansion from contraction. The composite index came in at 50.6, down from 51.2 in the previous month and touching a 13-month low.
----------
Iran sent mixed messages on whether it is ready to accept intrusive nuclear inspections foreseen in a deal with six world powers, following a visit by International Atomic Energy Agency chief Yukiya Amano in Tehran. Amano was expected to report back Friday in Vienna to the group of six, which are negotiating with Iran on scaling back the Islamic republic's nuclear programme and allow deep scrutiny by IAEA inspectors, in return for sanctions relief.
----------
An airstrike has killed a leading Islamic State fighter in Syria, the Pentagon said. Tunisian militant Tarik bin Tahar al-Awni al-Harzi was killed in Syria near the border with Iraq on June 16. His death would make it harder for Islamic State to move weapons and fighters in and out of Iraq and Syria, Pentagon spokesman Jeff Davis said in a statement.
----------
Syrian opposition rebels launched a large-scale attack on regime strongholds in the northern province of Aleppo, killing and wounding some 80 people, a monitoring group said. "This is the heaviest attack by rebel forces Aleppo has witnessed since two years, as more than 400 shells fell on regime-held areas in Aleppo," Rami Abdel Rahman, head of the Syrian Observatory for Human Rights, told dpa.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.